Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,365 total articles
NextCure, Inc. announced that Phase 1 clinical data for SIM0505, an investigational antibody drug conjugate targeting Cadherin-6 for the treatment of advanced solid tumors, will be presented at ASCO 2026. The results underscore forward progress in NextCure's oncology pipeline, focusing on innovative therapies for cancer including difficult-to-treat…
IP Strategy Holdings, Inc. has announced a 1-for-20 reverse stock split of its common stock effective April 23, 2026, aimed at complying with Nasdaq's minimum bid price requirements and improving stock liquidity. The reverse split will adjust shares and outstanding warrants proportionately without affecting authorized shares or shareholder rights e…
Cellectar Biosciences announced that a subset of data from their CLOVER WaM clinical trial involving iopofosine I-131 was accepted for presentation at the 2026 American Society of Clinical Oncology Annual Meeting. The data focuses on relapsed/refractory Waldenström macroglobulinemia (WM) patients who have progressed after treatment with BTK inhibit…
Progress Software released its 2025 Corporate Social Responsibility report showcasing a strong commitment to employee development, community engagement, and environmental sustainability. The report details expanded professional growth programs, support for global charitable initiatives especially in STEM education, and steps toward enhanced environ…
Disc Medicine announced that it will present new data from the RALLY-MF Phase 2 trial of DISC-0974, an investigational treatment for anemia in myelofibrosis patients, at the American Society of Clinical Oncology Annual Meeting in June 2026. Initial trial results showed unprecedented anemia response rates in a hard-to-treat population, with updated …
Cardiff Oncology announced it will present updated interim results from its Phase 2 trial evaluating onvansertib in combination with standard chemotherapy regimens for first-line treatment of RAS-mutated metastatic colorectal cancer. The presentation at ASCO 2026 underscores onvansertib's potential as a novel oral PLK1 inhibitor addressing a signif…
Holley Performance Brands (NYSE: HLLY) announced the launch of Holley High-Performance Car Care, a new line of automotive detailing products developed in partnership with Malco Automotive. This new product line expands Holley's American Performance chemicals portfolio into vehicle appearance care, targeting performance enthusiasts seeking high-qual…
SoundHound AI (Nasdaq: SOUN) announced it will acquire LivePerson (Nasdaq: LPSN) in a strategic transaction combining their voice AI and digital messaging capabilities. The deal aims to create a comprehensive, end-to-end omnichannel conversational AI platform serving over 25 Fortune 100 companies, with expanded vertical reach and significant revenu…
Edible Garden AG Incorporated announced a significant expansion of its fresh-cut herb supply to Target stores, increasing its retail footprint and expected to boost revenue growth. The company emphasizes its advanced controlled environment agriculture technology, sustainable operations, and patented innovations in farming and displays. This expande…
Silynxcom Ltd., a manufacturer of ruggedized tactical communication headsets, announced it received a $500,000 purchase order from a new military customer in Asia. The order furthers the company's expansion into the Asian defense market with their advanced in-ear tactical headset systems featuring superior noise reduction, 'hear-thru' technology, a…
SEALSQ Corp announces significant advancements in embedding Post-Quantum Cryptography (PQC) directly into semiconductor hardware to counter emerging AI-driven cybersecurity threats, highlighted by recent breakthroughs like Anthropic's Claude Mythos. The company emphasizes that hardware-based quantum-resistant cryptography offers superior protection…
Virtuix Inc. demonstrated its Virtual Terrain Walk (VTW) full-body VR system at the 4th Annual Immersive Technology Summit in Orlando before senior U.S. Department of Defense officials. The technology enables military personnel to rehearse missions in photorealistic, geo-specific virtual environments with unrestricted movement. This event highlight…
PacBio announced that Lucid Genomics has joined its Compatible partner program to provide tertiary analysis solutions optimized for PacBio's HiFi long-read sequencing technology. This partnership aims to streamline genomic data interpretation and accelerate the transition from sequencing results to actionable biological insights, benefiting researc…
Outlook Therapeutics announced the completion of a Federal Dispute Resolution meeting with the FDA concerning its biologics license application for ONS-5010/LYTENAVA™, an ophthalmic formulation of bevacizumab for treating wet age-related macular degeneration. The meeting aimed to seek alignment on the regulatory pathway after a Complete Response Le…
Root, Inc. released a national survey revealing that Baby Boomers are 2.2 times more likely than Gen Z to view traditional car insurance pricing as unfair, due to reliance on demographic factors rather than individual driving behavior. The report shows 95% of drivers prefer rates based on actual driving habits, and Root's behavior-based pricing can…
Stereotaxis, a leader in surgical robotics for minimally invasive endovascular intervention, announced its intention to release first quarter 2026 financial results on May 12, 2026. The company will host a conference call to discuss the results and corporate updates.
BOS Better Online Solutions Ltd. (Nasdaq: BOSC) announced a $350,000 extension to a previous RFID order from a major Israeli retail chain, bringing the total contract to $890,000. This extension highlights the customer's confidence in BOS's supply chain and inventory management solutions and underscores potential for further business growth in the …
NEXGEL, Inc. has closed the acquisition of a regenerative biomaterial product portfolio from Celularity Inc., financed by a $5.5 million strategic investment led by Sequence LifeScience. This transaction is expected to nearly triple NEXGEL’s annual revenue to approximately $35 million and be immediately accretive to profitability. The company has l…
Employers Holdings, Inc. (NYSE: EIG) announced the launch of its workers' compensation quoting app within the ChatGPT App Directory, marking the first known instance of an insurance carrier embedding quoting capabilities in a consumer AI platform. This innovation simplifies the quoting process by enabling businesses to obtain real-time premium esti…
Freight Technologies has launched the Fr8Tech AI Transformation Framework (FATF), a proprietary methodology to formalize and scale the use of agentic AI across its operations and software development. This framework supports significant productivity gains reported earlier, enhances product development velocity, and helps the company expand its AI-p…
Allied Gaming & Entertainment Inc. reports unusual volatility and high short-selling activity in its stock, prompting its Board to establish a special committee to investigate potential market manipulation and suspicious trading. The company emphasizes its strong liquidity position and clarifies that a reverse stock split is not currently anticipat…
Alpha Compute Corp., a US-listed AI infrastructure company, announced the appointment of Tom Richer to its Advisory Board. Richer brings over 30 years of experience in enterprise technology, AI infrastructure, and cloud architecture, and will provide strategic guidance as Alpha Compute expands its GPU-as-a-Service and confidential compute platform …
HII and Applied Intuition have signed a memorandum of understanding to collaborate on integrating Applied Intuition's AI-driven Warship OS into HII's next-generation naval platforms, including unmanned and manned vessels. This partnership aims to enhance naval capabilities through AI, improving ship performance, autonomy, and adaptability to evolvi…
Akari Therapeutics announced that its abstract on AKTX-101, an antibody drug conjugate targeting KRAS-mutated tumors, has been accepted for publication at the prestigious ASCO 2026 Annual Meeting. The data highlights the promise of AKTX-101’s novel RNA splicing modulator payload in treating difficult cancers, with plans to commence Phase 1 clinical…
Churchill Downs Incorporated has entered into a definitive agreement to acquire the intellectual property rights for the Preakness Stakes and Black-Eyed Susan Stakes for $85 million. The acquisition aligns with the company’s strategy to expand its portfolio of premier Thoroughbred racing assets, reinforcing its presence in the horse racing and spor…
